Medicine
Volume 35, Issue 8 , Pages 442-446 , August 2007

Management of chronic kidney disease

References 

  1. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775–1779
  2. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288:1909–1914
  3. Joint Specialty Committee for Renal disease of the Royal College of Physicians of London and the Renal Association . Chronic kidney disease in adults: UK guidelines for identification, management, and referral. London: Royal College of Physicians of London; 2006;
  4. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  5. The Royal College of Physicians of Edinburgh TSRA, and the Renal Association . UK consensus statement on chronic kidney disease. http://www.rcpe.ac.uk/Whats_New/consensus-statements/final-early-chronic-kidney-disease.doc2007;
  6. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002;61:2165–2175
  7. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int. 1984;26:861–868
  8. Fliser D, Franek E, Ritz E. Renal function in the elderly–is the dogma of an inexorable decline of renal function correct?. Nephrol Dial Transplant. 1997;12:1553–1555
  9. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int. 1989;36:272–279
  10. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139–185
  11. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244–252
  12. National Institute for Clinical Excellence . Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care. 1st edn. London: Royal College of Physicians; 2004;
  13. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet. 2003;361:117–124
  14. Ruggenenti P, Perna A, Benini R, Remuzzi G. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). J Am Soc Nephrol. 1998;9:2096–2101
  15. Sprangers B, Evenepoel P, Vanrenterghem Y. Late referral of patients with chronic kidney disease: no time to waste. Mayo Clin Proc. 2006;81:1487–1494

PII: S1357-3039(07)00147-8

doi: 10.1016/j.mpmed.2007.05.010

Medicine
Volume 35, Issue 8 , Pages 442-446 , August 2007

Article Tools